Nino from Berlin - Dx 2015
Posted: Wed Mar 15, 2023 12:42 pm
Hey everyone, I am Nino, 24yo from Berlin/Germany and I was diagnosed with ASPS last year.
I was on holidays with some friends in Sweden in July 2022 when I suddenly experienced three seizures within a matter of a few days. MRI in a swedish hospital revealed two lesions in my brain (1cm and 0.5cm).
Back in Germany the larger lesion was resected and diagnosis of an ASPS met was done. I had further staging scans like PET-CT, CT and MRIs which revealed some pulmonary nodules, though no hint to a primary tumor. There was a large lesion about 3.7cm in the right lower lobe and a few small ones <0.7cm. At first they wanted to start me on pazopanib. After some research I found out that ASPS can be misdiagnosed as arteriovenous malformation which I had one resected (6cmx2cm) in March 2015 from my right calf, for which I was in and out of hospitals since 2012.
Pathology back then did not reveal any malignancy. I told that to my sarcoma oncologist and she requested the pathology report to be redone and indeed it revealed ASPS. After that the plan was to resect the other brain lesion and the largest nodule from my right lung. So another craniotomy was done and I received ~25gy radiation after resection over a course of two weeks to the resected areas. After that a UVATS was done to remove the large nodule in my left lung. Pathology revealed that it consisted of 4 mets, the largest being max. 3cmx2cmx1cm. A month after that decision was made to remove nodules on my right lung as well. 10 resections were made, but only 6 were confirmed to be ASPS, one was even noted as almost entirely regressed.
Anyways, on my next CT and MRIs at the start of February two new lesions were found in my brain. One 8mmx4mmx3mm, which in retrospective was already visible on scans in July 2022 (~1-1.5mm) and one small lesion which did not have any dimensions mentioned. On scans it does not look much larger than around 2mm. Other scans were clear. To both I received STS with around 27gy in a single fraction just two weeks ago.
I had also a separate MRI done to my calves as the primary was most likely not resected with negative margins back in 2015. MRI revealed a small lesion in the Tibia, around 9mmx6mm. Pathology report said it might be an AVM or residual disease/recurrence of ASPS. My oncologist says it is unlikely that it is a recurrence, especially after that long time, but they will keep an eye on it. The scan in February did note that the measurements stayed the same.
Because of the dynamics in new brain lesions (which I received STS to) they want to start me on systemic therapy as soon as possible. They requested Pembro/Axitinib combination at my health insurance and that might take some more weeks to get approved.
I am unsure about going that route right away. I have done a lot of research within the past 6 months regarding ASPS, systemic treatment and also treatment in malignant melanoma and ccRCC. I do not see a reason to go both TKI and Immunotherapy just yet (though that might change if the next scans show many new lesions). As some published expert opinions on RCC state that on NED disease with TKI/Imm combination one might encounter unnecessary resistance to both drugs and unnecessary toxicity and that it might impact sequential treatment lines.
If the next scan would not show any new lesions, which we know might happen with the course of this disease - maybe mono-immunotherapy might be enough for now -> looking at KEYNOTE studies done on RCC, which showed no benefit in using TKIs as adjuvant treatment, though in the KEYNOTE 564 study adjuvant pembrolizumab showed great benefit in the M1 NED group, although both drug and placebo group were rather small to draw definite conclusions.
Also I am cautious about using TKIs on brain mets as quite some reports on ASPS brain mets treated with TKIs mention cranial hemorrhaging and seizures.
I was on holidays with some friends in Sweden in July 2022 when I suddenly experienced three seizures within a matter of a few days. MRI in a swedish hospital revealed two lesions in my brain (1cm and 0.5cm).
Back in Germany the larger lesion was resected and diagnosis of an ASPS met was done. I had further staging scans like PET-CT, CT and MRIs which revealed some pulmonary nodules, though no hint to a primary tumor. There was a large lesion about 3.7cm in the right lower lobe and a few small ones <0.7cm. At first they wanted to start me on pazopanib. After some research I found out that ASPS can be misdiagnosed as arteriovenous malformation which I had one resected (6cmx2cm) in March 2015 from my right calf, for which I was in and out of hospitals since 2012.
Pathology back then did not reveal any malignancy. I told that to my sarcoma oncologist and she requested the pathology report to be redone and indeed it revealed ASPS. After that the plan was to resect the other brain lesion and the largest nodule from my right lung. So another craniotomy was done and I received ~25gy radiation after resection over a course of two weeks to the resected areas. After that a UVATS was done to remove the large nodule in my left lung. Pathology revealed that it consisted of 4 mets, the largest being max. 3cmx2cmx1cm. A month after that decision was made to remove nodules on my right lung as well. 10 resections were made, but only 6 were confirmed to be ASPS, one was even noted as almost entirely regressed.
Anyways, on my next CT and MRIs at the start of February two new lesions were found in my brain. One 8mmx4mmx3mm, which in retrospective was already visible on scans in July 2022 (~1-1.5mm) and one small lesion which did not have any dimensions mentioned. On scans it does not look much larger than around 2mm. Other scans were clear. To both I received STS with around 27gy in a single fraction just two weeks ago.
I had also a separate MRI done to my calves as the primary was most likely not resected with negative margins back in 2015. MRI revealed a small lesion in the Tibia, around 9mmx6mm. Pathology report said it might be an AVM or residual disease/recurrence of ASPS. My oncologist says it is unlikely that it is a recurrence, especially after that long time, but they will keep an eye on it. The scan in February did note that the measurements stayed the same.
Because of the dynamics in new brain lesions (which I received STS to) they want to start me on systemic therapy as soon as possible. They requested Pembro/Axitinib combination at my health insurance and that might take some more weeks to get approved.
I am unsure about going that route right away. I have done a lot of research within the past 6 months regarding ASPS, systemic treatment and also treatment in malignant melanoma and ccRCC. I do not see a reason to go both TKI and Immunotherapy just yet (though that might change if the next scans show many new lesions). As some published expert opinions on RCC state that on NED disease with TKI/Imm combination one might encounter unnecessary resistance to both drugs and unnecessary toxicity and that it might impact sequential treatment lines.
If the next scan would not show any new lesions, which we know might happen with the course of this disease - maybe mono-immunotherapy might be enough for now -> looking at KEYNOTE studies done on RCC, which showed no benefit in using TKIs as adjuvant treatment, though in the KEYNOTE 564 study adjuvant pembrolizumab showed great benefit in the M1 NED group, although both drug and placebo group were rather small to draw definite conclusions.
Also I am cautious about using TKIs on brain mets as quite some reports on ASPS brain mets treated with TKIs mention cranial hemorrhaging and seizures.